We are live on
!
Find out more
VCNX
Vaccinex, Inc. Common Stock
VCNX
VCNX
Delisted
VCNX was delisted on the 17th of December, 2024.
12 hedge funds and large institutions have $1.14M invested in Vaccinex, Inc. Common Stock in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
9% more funds holding
Funds holding: 11 → 12 (+1)
37% less capital invested
Capital invested by funds: $1.81M → $1.14M (-$667K)
Holders
12
Holders Change
+1
Holders Change %
+9.09%
% of All Funds
0.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
4
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
AC
Armistice Capital
New York
|
+$394K |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$278K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$19.1K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.15K |
| 5 |
Barclays
London,
United Kingdom
|
+$152 |
Top Sellers
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$424K |
| 2 |
Morgan Stanley
New York
|
-$6.24K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$11 |